Protein Production in Mammalian Cells

Mammalian cells are an important host for the production of clinically relevant recombinant proteins. The most widely used approach for this purpose is to establish a cell line with an actively expressed recombinant gene stably integrated in its genome. Alternatively, protein can be transiently produced in cells for a few days immediately after deoxyribonucleic acid (DNA) transfer without the necessity of recombinant gene integration.

Keywords: recombinant protein; mammalian cells; DNA transfection; bioreactor; gene expression

 References
    Barnes LM, Bentley CM and Dickson AJ (2000) Advances in animal cell recombinant protein production: GS-NS0 expression system. Cytotechnology 32: 109–123.
    Boussif O, Lezoualc’h F, Zanta MA et al. (1995) A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proceedings of the National Academy of Sciences of the USA 92: 7297–7301.
    Derouazi M, Girard P, Van Tilborgh F et al. (2004) Serum-free large-scale transient transfection of CHO cells. Biotechnology and Bioengineering 87: 537–545.
    Jordan M and Wurm FM (2004) Transfection of adherent and suspended cells by calcium phosphate. Methods 33: 136–143.
    Makrides SC (1999) Components of vectors for gene transfer and expression in mammalian cells. Protein Expression and Purification 17: 183–202.
    Meissner P, Pick H, Kulangara A et al. (2001) Transient gene expression: recombinant protein production with suspension-adapted HEK293-EBNA cells. Biotechnology and Bioengineering 75: 197–203.
    Pellicer A, Wigler M and Axel R (1978) The transfer and stable integration of the HSV thymidine kinase gene into mouse cells. Cell 14: 133–141.
    Reichert JM (2006) Trends in US approvals: new biopharmaceuticals and vaccines. Trends in Biotechnology 24: 293–298.
    Ringold G, Dieckmann B and Lee F (1981) Co-expression and amplification of dihydrofolate reductase cDNA and the Escherichia coli XGPRT gene in Chinese hamster ovary cells. Journal of Molecular and Applied Genetics 1: 165–175.
    Wurm FM (2004) Production of recombinant protein therapeutics in cultivated mammalian cells. Nature Biotechnology 22: 1393–1398.
 Further Reading
    Adams GP and Weiner LM (2005) Monoclonal antibody therapy of cancer. Nature Biotechnology 23: 1147–1157.
    Anderson DC and Krummen L (2002) Recombinant protein expression for therapeutic applications. Current Opinion in Biotechnology 13: 117–123.
    Dinnis DM and James DC (2005) Engineering mammalian cells factories for improved recombinant monoclonal antibody production: lessons from nature? Biotechnology and Bioengineering 91: 180–189.
    Kwaks THJ and Otte A (2006) Employing epigenetics to augment the expression of therapeutic proteins in mammalian cells. Trends in Biotechnology 24: 137–142.
    Lechardeur D, Verkman AS and Lukacs GL (2005) Intracellular routing of plasmid DNA during non-viral gene transfer. Advanced Drug Delivery Reviews 57: 755–767.
    book Smales CM and James DC (eds) (2005) Therapeutic Proteins: Methods and Protocols. Totowa, NJ: Humana Press.
    Wurm F and Bernard A (1999) Large-scale transient expression in mammalian cells for recombinant protein production. Current Opinion in Biotechnology 10: 156–159.
Contact Editor close
Submit a note to the editor about this article by filling in the form below.

* Required Field

How to Cite close
Hacker, David L, and Wurn, Florian M(Sep 2007) Protein Production in Mammalian Cells. In: eLS. John Wiley & Sons Ltd, Chichester. http://www.els.net [doi: 10.1002/9780470015902.a0020209]